11 hours ago
UK Probes Genetic Link Between Obesity Drugs and Pancreas Damage
The UK is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there's a genetic risk for the condition.
The country's drug regulator, alongside Genomics England, is investigating whether a person's genetics might make them more vulnerable to acute pancreatitis — a potential serious side effect of Novo Nordisk A/S and Eli Lilly & Co. 's blockbusters.
